Cornercap Investment Counsel Inc Monte Rosa Therapeutics, Inc. Transaction History
Cornercap Investment Counsel Inc
- $637 Million
- Q1 2024
A detailed history of Cornercap Investment Counsel Inc transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Cornercap Investment Counsel Inc holds 42,393 shares of GLUE stock, worth $164,908. This represents 0.05% of its overall portfolio holdings.
Number of Shares
42,393
Previous 27,844
52.25%
Holding current value
$164,908
Previous $157,000
89.81%
% of portfolio
0.05%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding GLUE
# of Institutions
71Shares Held
34.5MCall Options Held
80.3KPut Options Held
12.6K-
Nea Management Company, LLC Timonium, MD7.69MShares$29.9 Million3.81% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.1MShares$19.8 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY4.92MShares$19.1 Million0.44% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.54MShares$17.6 Million0.39% of portfolio
-
Black Rock Inc. New York, NY2.31MShares$8.97 Million0.0% of portfolio
About Monte Rosa Therapeutics, Inc.
- Ticker GLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,713,900
- Market Cap $182M
- Description
- Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...